MRD (Minimal Residual Disease) Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global MRD (Minimal Residual Disease) Testing Market is predicted to grow at a CAGR of 15% over the forecast period, 2021-2027.

The minimal residual disease test is useful for identifying traces of leukemia cells during and after cancer treatment. The different treatments used during the onset of disease can be tested with minimal residual disease to confirm the efficacy of the various tests and choose the best treatment for eradicating cancer cells. The minimal residual disease test can quantitatively measure cancer recurrence and cell proliferation. Continuous treatment of cancer with chemotherapy or radiation therapy cannot eliminate all cancerous cells, and moreover, it can cause malignant tumors.

Market Segments

By the product type

• Flow Cytometry
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)

By the end-users/application

• Specialty Clinics and Hospitals
• Diagnostic Laboratories
• Research Institutions

Key Players

• ArcherDX(Invitae)
• ARUP Laboratories
• Asuragen
• Cergentis B.V.
• Bio-Rad Laboratories
• Mission Bio
• Guardant Health
• Invivoscribe

Scope of the Report

The research study analyzes the global MRD (Minimal Residual Disease) Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by MRD (Minimal Residual Disease) Testing Market Report

1. What was the MRD (Minimal Residual Disease) Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the MRD (Minimal Residual Disease) Testing Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the MRD (Minimal Residual Disease) Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.